TY - JOUR
T1 - Pigment epithelium-derived factor exerts opposite effects on endothelial cells of different phenotypes
AU - Hutchings, Helen
AU - Maitre-Boube, Martine
AU - Tombran-Tink, Joyce
AU - Plouët, Jean
N1 - Funding Information:
This work was supported by grants from Retina France and La Ligue Nationale Contre le Cancer (Equipe Labellisée).
PY - 2002/1/1
Y1 - 2002/1/1
N2 - The anti-angiogenic activity of pigment epithelium-derived factor (PEDF) has recently been discovered on the basis of its inhibition of ischemia-induced retinal neovascularization in an animal model of retinopathy of the premature. Moreover PEDF inhibits the migration and proliferation of various endothelial cells maintained in culture with FGF2. Since vascular endothelial growth factor (VEGF) is the main angiogenic factor expressed in hypervascularized retinas, we investigated the functions of PEDF on retinal endothelial cells whose angiogenic phenotype is controlled or not by long term exposure to VEGF as observed in human pathologies such as diabetic retinopathy. Here, we observed that PEDF exerts opposite effects on endothelial cells depending on their phenotype. We determined that when PEDF inhibits endothelial cell growth, it inhibits VEGF-induced MAPK activation. However, in endothelial cells cultured with VEGF, PEDF has a synergistic action on cell proliferation with VEGF, and this corresponds to increased MAPK activation.
AB - The anti-angiogenic activity of pigment epithelium-derived factor (PEDF) has recently been discovered on the basis of its inhibition of ischemia-induced retinal neovascularization in an animal model of retinopathy of the premature. Moreover PEDF inhibits the migration and proliferation of various endothelial cells maintained in culture with FGF2. Since vascular endothelial growth factor (VEGF) is the main angiogenic factor expressed in hypervascularized retinas, we investigated the functions of PEDF on retinal endothelial cells whose angiogenic phenotype is controlled or not by long term exposure to VEGF as observed in human pathologies such as diabetic retinopathy. Here, we observed that PEDF exerts opposite effects on endothelial cells depending on their phenotype. We determined that when PEDF inhibits endothelial cell growth, it inhibits VEGF-induced MAPK activation. However, in endothelial cells cultured with VEGF, PEDF has a synergistic action on cell proliferation with VEGF, and this corresponds to increased MAPK activation.
UR - http://www.scopus.com/inward/record.url?scp=0036297892&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036297892&partnerID=8YFLogxK
U2 - 10.1016/S0006-291X(02)00548-X
DO - 10.1016/S0006-291X(02)00548-X
M3 - Article
C2 - 12061772
AN - SCOPUS:0036297892
SN - 0006-291X
VL - 294
SP - 764
EP - 769
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 4
ER -